Consequences of the development of nisin-resistant Listeria monocytogenes in fermented dairy products.
Wild Listeria isolates representing serovars found in artisanal cheeses commercialized in Asturias (northern Spain) were assessed for their susceptibility to several bacteriocins. Pediocin PA-1 was the most active bacteriocin followed by enterocin AS-48, nisin, and plantaricin C. However, some Listeria monocytogenes and Listeria innocua strains were already highly resistant to PA-1. Among the wild L. monocytogenes populations, the frequency of development of nisin resistance ranged from 10(-6) up to 10(-3), depending on the strain. Highly stable mutants with increased nisin resistance (two- to fourfold) were isolated and tested for potential cross-resistance to lysozyme, EDTA, and various NaCl concentrations and pH values. All mutants were cross-resistant to lysozyme but sensitive to EDTA. In contrast, no clear correlation could be established between nisin resistance and an altered susceptibility to NaCl or pH changes. Nisin-resistant variants were able to survive and even to multiply in milk fermented by a nisin-producing Lactococcus, but the growth of the wild-type strain was inhibited. The different phenotypes evaluated in this study are indicative of the unpredictability of the consequences of the development of nisin resistance in a dairy environment. This resistance should be considered when making a risk assessment of the long-term use of nisin to control L. monocytogenes.
Martínez
Beatriz
B
Instituto de Productos Lácteos de Asturias, Consejo Superior de Investigaciones Cientificas, 33300 Villaviciosa, Asturias, Spain. bmf1@ipla.csic.es
Bravo
Diego
D
Rodríguez
Ana
A
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001430:Bacteriocins / Q000494:pharmacology; D015169:Colony Count, Microbial; D003257:Consumer Product Safety; D043302:Cultured Milk Products / Q000382:microbiology*; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D006863:Hydrogen-Ion Concentration; D008089:Listeria monocytogenes / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development*; D008826:Microbial Sensitivity Tests; D009113:Muramidase / Q000494:pharmacology; D009154:Mutation; D009561:Nisin / Q000494:pharmacology*; D000070017:Pediocins; D018570:Risk Assessment; D012965:Sodium Chloride / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001430:Bacteriocins; D000070017:Pediocins; C074288:pediocin PA-1; D009561:Nisin; D012965:Sodium Chloride; D009113:Muramidase